Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 20 May 2024 for BriaCell Therapeutics Corp., €1.8M.
Filing timeline
BuySaleMarc Lustig
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +138.3%Entry US$14.90 · Close at T+365 US$35.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Marc Lustig: trading record in brief
Only one filing by Marc Lustig is known so far (20 May 2024): an open-market purchase, €1.8M, in BriaCell Therapeutics Corp. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Marc Lustig
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
902,935 shares@ US$2.215100.0% of flowCommon SharesSEC:0001493152-24-020660:0
Canonical exit: 12 Aug 2024 (T+90)
1 of 1 declaration
